Peripartum Cardiomyopathy

Zoltàn Arany

doi:10.1056/nejmra2306667

January 10, 2024New England Journal of Medicine

Peripartum Cardiomyopathy

View at Publisher

Ask AI

Bookmark

Share

Key Points

Examine the epidemiology, clinical characteristics, and molecular mechanisms of peripartum cardiomyopathy to identify targets for novel treatments.
Narrative review synthesizing evidence on the epidemiology and clinical manifestation of peripartum cardiomyopathy.
Analysis of pathological mechanisms to evaluate therapeutic avenues.
Summarizes epidemiological distribution and clinical features observed in women presenting with peripartum heart dysfunction.
Identifies biological disease mechanisms to guide the development of potential targeted therapies.

Design

Review

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This article reviews the epidemiology, clinical presentation, and mechanistic basis for potential therapeutics in peripartum cardiomyopathy.

Abstract

The author discusses the epidemiology and clinical presentation of peripartum cardiomyopathy, as well as the mechanistic basis for potential therapeutics.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zoltàn Arany (2024) studied this question.

synapsesocial.com/papers/69fd294430a474415f89e0e8 https://doi.org/10.1056/nejmra2306667

View at Publisher

Ask AI

Bookmark

Share

Peripartum Cardiomyopathy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Peripartum Cardiomyopathy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading